Efficacy of newer antidepressants for childhood anxiety disorders

References

• Shaffer D, Fisher P, Dulcan MK et al The NNE Diagnostic Interview for Children Version 2.3 (DISC 2.3) Description, acceptability, prevalence rates and performance in the MECA study. Am. Acad. Child Adolesc Psythiatry35, 865–877 (1995).
   Google Scholar
• Verhulst PC, van der Ende J, Ferdinand RF,Kasius MC. The prevalence of DSM-III-R diagnoses in a normal sample of Dutch adolescents. Arch. Gen. Rychiatry 54, 329–336 (1997).
   Google Scholar
• Last CG, Perrin S, Hersen M eta]. DSM-III-R anxiety disorders in children: sociodemographic and clinical characteristics. jAm. Acad. Child Adolesc. Psychiatry 31,1070–1076 (1992).
   Google Scholar
• Masi G, Favilla L, Mucci M, Millepiedi S.Depressive comorbidity in children and adolescents with generalized anxiety disorder. Child Psychiatry Hum. Dev. 30, 205–215 (2000).
   Web of Science ®Google Scholar
• Masi G, Toni C, Perugi G, Mucci M,Millepiedi S, Akiskal HS. Anxiety comorbidity in consecutively referred children and adolescents with bipolar disorder: a neglected comorbidity. Can. J. Bychiatry 46,766–771 (2001).
   Google Scholar
• Last CG, Perrin S, Hersen M, Kazdin AE.A prospective study of childhood anxiety disorders. J. Arn. Acad. Child Adolesc. Bychiatry35, 1502–1510 (1996).
   PubMed Web of Science ®Google Scholar
• •A pivotal study of longitudinal outcome of childhood anxiety disorders.
   Google Scholar
• Pine DS, Cohen P, Gurley D, Brook J, MaY. The risk of early adulthood anxiety and depressive disorders in adolescent with anxiety and depressive disorders. Arch. Gen. Bychiatry55, 123–129 (1998).
   Google Scholar
• •A nice study of natural history in anxiety and depressive disorders.
   Google Scholar
• Coyle JT Drug treatment of anxietydisorders in children. N Engl. J. Med. 344, 1326–1327 (2001).
   Google Scholar
• American Academy of Child andAdolescent Psychiatry. Practice guidelines for the assessment and treatment of anxiety disorders. jAm. Acad. Child Adolesc. Psychiatry 36 (Suppl.), 69S-84S (1997) .
   Google Scholar
• Allen AJ, Leonard H, Swedo SE. Current knowledge of medications for the treatment of childhood anxiety disorders. jAm. Acad. Child Adolesc. Psychiatry 134,976–986 (1995).
   Google Scholar
• Emslie GJ, Walkup JT, Pliszka SR, Ernst M.Nontrycyclic antidepressants: current trends in children and adolescents. J. Am. Acad. Child Adolesc. Bychiatry38, 517–528 (1999).
   Google Scholar
• Leonard HL, March J, Ricckler KC, AllenAJ. Pharmacology of selective serotonin uptake inhibitors inhibitors in children and adolescents. jAm Acad. Child Adolesc. Bychiatry36, 725–736 (1997).
   PubMed Web of Science ®Google Scholar
• ••A good review of pharmacological aspectsin the pediatric use of SSR1s.
   Google Scholar
• Stahl SM. Essential psychopharmacology(2nd Edition), Cambridge University Press, New York, NY, USA (2000).
   Google Scholar
• McConville BJ, Chaney RO, Browne KLetal Newer antidepressants. Beyond selective serotonin re-uptake inhibitor antidepressants. Pecliatr Clin. N Am. 45, 1157–1171 (1998).
   PubMed Web of Science ®Google Scholar
• Flament ME, Koby E, Rapoport JL et alChildhood obsessive-compulsive disorder: a prospective follow-up study. J. Child Bychol Psychiatry31, 363–380 (1990).
   PubMed Web of Science ®Google Scholar
• Rapoport JL, Inoff-Germain G.Practitioner review: treatment of obsessive-compulsive disorder in children and adolescents. J. Child Psycho'. Psychiatry 41, 419–431 (2000).
   PubMed Web of Science ®Google Scholar
• Leckman JF, Grice DE, Boardman J etalSymptoms of obsessive-compulsive disorder. Am.j PFchiatry154,911–917 (1997).
   PubMed Web of Science ®Google Scholar
• De Veaugh-Geiss J, Moroz G, Biederman Jeta]. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder - a multicenter trial. Am. Acad. Child Adolesc. Psychiatry31(1), 45–49 (1992).
   Google Scholar
• March JS, Biederman J, Wolkow R et alSertraline in children with obsessive-compulsive disorder: a multicenter randomized controlled trial. jAm. Med. Assn. 280,1752–1756 (1998).
   PubMed Web of Science ®Google Scholar
• •An important controlled study on sertraline use in pediatric OCD.
   Google Scholar
• Riddle MA, Reeve EA, Yaryura-Tobias JAeta]. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. j Am. Acad. Child Adolesc. Psychiatry 40, 222–229 (2001).
   Google Scholar
• Geller DA, Hoog SL, Heiligenstein JHetal Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. jAm. Acad. Child Adolesc. Psychiatry 40,773–779 (2001).
   PubMed Web of Science ®Google Scholar
• Rosenberg DR, Stewart CM, Fitzgerald KD, Tawile V, Carrol E. Paroxetine open-label treatment of pediatric out-patients with obsessive-compulsive disorder. J. Am. Acad. Child Adolesc. Psychiatry 38,1180–1185 (1999).
   PubMed Web of Science ®Google Scholar
• Thomsen PH. Child and adolescentobsessive-compulsive disorder treated with citalopram: findings from an open trial of 23 cases. J. Child Adolesc. Psychopharmacvol 7,157–166 (1997).
   Google Scholar
• Greist J, Chouinard G, DuBoff E et alDouble-blind, parallel comparison of three dosages of sertraline and placebo in out-patients with obsessive-compulsive disorder. Arch. Gen. PFchiatry59, 289–295 (1995).
   Google Scholar
• McDougle CJ. Update on pharmacologicmanagement of OCD: agents and augmentation. J. Clin. Bychiatry58\(Suppl. 12), 11–17 (1997).
   Google Scholar
• Leonard HL, Swedo S, Lenane MC et al Adouble-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Arch. Gen. Psychiatry 48,922–927 (1991).
   PubMed Web of Science ®Google Scholar
• March JS, Frances A, Carpenter D, KahnDA. The Expert Consensus Guideline Series: treatment of obsessive compulsive disorder. J. Clin. PTchiatry58\(Suppl. 4), 1–72 (1997).
   Google Scholar
• Thomsen PH, Ebbesen C, Persson C.Long-term experience with citalopram in the treatment of adolescent OCD. J. Am. Acad. Child Adolesc. Psychiatry40, 895–902 (2001).
   PubMed Web of Science ®Google Scholar
• Cook EH, Wagner KD, March JS et alLong-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. jAm. Acad. Child Adolesc. Psychiatry 40, 1175–1181 (2001).
   PubMed Web of Science ®Google Scholar
• Von Korff M, Eaton W Keyl P. Theepidemiology of panic attacks and panic disorders: results of three community surveys. Am. J. Epidemiol 122,970–981 (1985).
   PubMedGoogle Scholar
• Wittchen HU, Reed V, Kessler RC. The relationship of agoraphobia and panic in a community sample of adolescents and young adults. Arch. Gen. PFchiatry55, 1017–1024 (1998).
   Google Scholar
• Biederman J, Faraone SV, Marrs A etalPanic disorder and agoraphobia in consecutively referred children and adolescents. jAm. Acad. Child Adolesc. Psychiatry36, 214–223 (1997).
   PubMed Web of Science ®Google Scholar
• Masi G, Favilla L, Mucci M, Millepiedi S.Panic disorder in clinically referred children and adolescents. Child Psychiatry Hum. Dev 31,139–151 (2000).
   PubMed Web of Science ®Google Scholar
• Weissmann MM, Bland RC, Canino GJ et al. The cross-national epidemiology of panic disorder. Arch. Gen. Psychiatry 54, 305–309 (1997).
   PubMedGoogle Scholar
• Klein DF, Mannuzza S, Chapman T, FyerA. Child panic revisited. jAm. Acad. Child Adolesc. PFchiatry31, 112–116 (1992).
   PubMedGoogle Scholar
• Toni C, Perugi G, Frare F et al A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants. Pharmacopsychiatry33, 121–131 (2000).
   PubMed Web of Science ®Google Scholar
• •An important, naturalistic study on efficacy of antidepressants in a larger sample of subjects with panic disorder.
   Google Scholar
• Lepola U, Leinonen E, Koponen H.Citalopram in the treatment of early-onset panic disorder and school-phobia. Pharmacopsychiatry29, 30–32 (1996).
   Google Scholar
• Fairbanks JM, Pine DS, Tancer NK etalOpen fluoxetine treatment of mixed anxiety disorders in children and adolescents. J. Child Adolesc. Ptychopharmacol 7,17–29 (1997).
   PubMed Web of Science ®Google Scholar
• Renaud J, Birmaher B, Wassick SC, BridgeJ. Use of selective serotonin re-uptake inhibitors for the treatment of childhood panic disorder: a pilot study. I Child Adolesc. Ptychopharmacol 9,73–83 (1999).
   PubMed Web of Science ®Google Scholar
• Masi G, Toni C, Mucci M, Millepiedi S, Mata B, Perugi G. Paroxetine in child and adolescent out-patients with panic disorder.Child Adolesc. Bychopharmacol 11,151–157 (2001).
   PubMed Web of Science ®Google Scholar
• Masi G, Mucci M, Millepiedi S. Separation anxiety disorder in children and adolescents: epidemiology, diagnosis and management. CNS Drugs 15,93–104 (2001).
   PubMed Web of Science ®Google Scholar
• Last CG, Francis G, Hersen M etal Separation anxiety and school phobia: a comparison using DSM III criteria. Am. J. Ptychiatry144,653–657 (1987).
   PubMed Web of Science ®Google Scholar
• Silove D, Manicavasagar V. Adults who feared school: is early separation anxiety specific to the pathogenesis of panic disorder? Ada Psychiatr Land. 88(6), 385–390 (1993).
   Google Scholar
• Silove D, Harris M, Morgan A eta]. Is early separation anxiety a specific precursor of panic disorder-agoraphobia? A community study. Psychol. Med. 25(2), 405–411 (1995).
   Google Scholar
• Silove D, Manicavasagar V, OConnel D eta]. Reported early separation anxiety symptoms in patients with panic and generalized anxiety disorders. Aust. NZI. Ptychiatry27 (3), 489–494 (1993).
   Google Scholar
• •A pivotal paper addressing the issue of separation anxiety disorders in adults.
   Google Scholar
• Manicavasagar V, Silove D, Hadzi-Pavlovic D. Subpopulations of early separation anxiety: relevance to risk of adult anxiety disorder. J. Affect. Disord 48 (2–3), 181–190 (1998).
   Google Scholar
• Manassis K, Bradley S. Fluoxetine in anxiety disorders. jAm. Acad. Child Adolesc. fiychtry33, 761–762 (1994).
   PubMed Web of Science ®Google Scholar
• Birmaher B, Waterman GS, Ryan N eta]. Fluoxetine for childhood anxiety disorders. Am. Acad. Child Adolesc. Bychiatry 33, 993–999 (1994).
   PubMed Web of Science ®Google Scholar
• Research Unit on Pediatric Psychopharmacology. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. N Engl. J. Med. 344,1279–1285 (2001).
   Google Scholar
• ••An important controlled study onpharmacological treatment in mixed anxiety disorders.
   Google Scholar
• Masi G, Mucci M, Favilla L, Romano R, Poli P Symptomatology and comorbidity of generalized anxiety disorder. Comprehen. Psychiatry40, 210–215 (1999).
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Zhao S, Kessler RC, Eaves WW DSM-III-R generalized anxiety disorder in a National Comorbidity Survey. Arch. Gen. Psychiatty51, 355–364 (1994).
   PubMed Web of Science ®Google Scholar
• Hoen-Sarlic R, Hazlett Fl, McLeod DR. Generalized anxiety disorder with early and late onset of anxiety symptoms. Compr. Psychiatry34, 291–298 (1993).
   Google Scholar
• Blazer DG, Hughes D, George LK. Stressful life events and the onset of the generalized anxiety disorder syndrome. Am.Bychiatry 144,1178–1183 (1987).
   Google Scholar
• Bernstein GA, Rapaport JL, Leonard HL.Separation anxiety disorder and generalized anxiety disorder. In: Textbook of Child and Adolescent Psychiatry Wiener JM (Ed.), American Psychiatric Press, Washington, DC, USA, 467–480 (1997).
   Google Scholar
• Ialongo N, Edelsohn G, Werthamer-Larsson L, Crockett L, Kellam S. The significance of self reported anxious symptoms in first grade children: prediction to anxious symptoms and adaptive functioning in fifth grade. J. Child Psychol. Ptychiatty 36,427–437 (1995).
   Google Scholar
• •The role of anxiety symptoms in the real life of affected children.
   Google Scholar
• Rynn MA, Siqueland L, Rickels K. Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am. J. fiychiatry 158, 2008–2014 (2001).
   Google Scholar
• Biedel DC. Social anxiety disorder: etiology and early clinical presentation. J. Clin. Psychiatry59\(Suppl. 17), 27–31 (1998).
   Google Scholar
• Beidel DC, Turner SM, Morris TL. Psychopathology of childhood social phobia. jAm. Acad. Child Adolesc. Ptychiatry38, 643–650 (1999).
   Google Scholar
• Biederman J, Rosenbaum JF, Bolduc-Murphy EA eta]. A 3-year follow-up of children with and without behavioral inhibition. jAm. Acad. Child Adolesc. Ptychiatry32, 815–821 (1993).
   Google Scholar
• ••An important paper addressing the issueof the role of temperamental traits as a vulnerability factor for anxiety disorders.
   Google Scholar
• Black B, Uhde TW. Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study. jAm. Acad. Child Adolesc. Psychiatry 33,1000–1006 (1994).
   PubMed Web of Science ®Google Scholar
• Dummit E, Klein R, Tancer N etal Fluoxetine treatment of children with selective mutism: an open trial. jAm. Acad. Child Adolesc. Psychiatry 35,615–621 (1996).
   PubMed Web of Science ®Google Scholar
• Mancini C, van Ameringen M, Oakman J,Farvolden P Serotonergic agents in the treatment of social phobia in children and adolescents. Depress. Anxiety 10,33–39 (1999).
   PubMed Web of Science ®Google Scholar
• Compton SN, Grant PJ, Chrisman AK, Gammon PJ, Brown VL, March JS. Sertraline in children and adolescents with social anxiety disorder: an open trial. J. Am. Acad. Child Adolesc. Psychiatry40, 564–571 (2001).
   PubMed Web of Science ®Google Scholar
• Scheeringa MS, Zeanah CH, Drell MJ, Larrieu JA. Two approaches to diagnosing posttraumatic stress disorder in infancy and early childhood. jAm. Acad. Child Adolesc. Ptychiatry34, 191–200 (1995).
   PubMed Web of Science ®Google Scholar
• ••A paper addressing the crucial point of thespecificity of the diagnosis of PTSD in young children.
   Google Scholar
• Lyons JA. Posttraumatic stress disorder in children and adolescents: a review of the literature. j Dev. &hay. Pecliatr 8,349–356 (1987).
   PubMed Web of Science ®Google Scholar
• Berliner L. Intervention with children who experienced trauma. In:The effects of trauma and the developmental pmcess. Cicchetti D, Toth S (Eds). Wiley, New York, USA, 491–514 (1997).
   Google Scholar
• Donnelly CL, Amaya-Jackson L, March JS. Psychopharmacology of pediatric posttraumatic stress disorder. J. Child Adolesc. Psychopharmacol 9,203–220 (1999).
   PubMed Web of Science ®Google Scholar
• •One of the few review on pharmacological treatment of pediatric PTSD.
   Google Scholar
• Hageman I, Andersen HL, Jorgensen MB.Post-traumatic stress disorder: a review of psychobiology and pharmacotherapy. Acta fiychiatr Scam 104, 411–422 (2001).
   PubMed Web of Science ®Google Scholar
• Stein DJ, Seedat S, van der Linden GJ,Zungu-Dirwayi N. Selective serotonin re-uptake inhibitors in the treatment of post-traumatic stress disorder: a meta-analysis of randomized controlled trials. Int. Clin. Bychopharmacol 15\(Suppl. 2), 31–39 (2000).
   Google Scholar
• Tucker P, Zaninelli R, Yehuda R, Ruggiero L, Dillingham K, Pitts CD. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J. Gun. Bychiatry62, 860–868 (2001).
   Google Scholar
• Davidson JR, Rothbaum BO, van der KolkBA, Sikes CR, Farfel GM. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch. Gen. RychMtry58, 485–492 (2001).
   Google Scholar
• Davis LL, Nugent AL, Murray J, Kramer GL, Petty E Nefazodone treatment for chronic posttraumatic stress disorder: an open trial. J. Gun. Rychopharmacol 20, 159–164 (2000).
   PubMedGoogle Scholar
• Masi G, Cosenza A, Mucci M,Brovedani P. Open trial of risperidone in 24 young children with pervasive developmental disorders. J. Am. Acad. Child. Ado]. Psychiatry 40, 1206–1214 (2001).
   Google Scholar